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Dynactin is a required cofactor for the minus-end-
directed microtubule motor cytoplasmic dynein. Mu-
tations within the highly conserved CAP-Gly domain
of dynactin cause neurodegenerative disease. Here,
we show that the CAP-Gly domain is necessary to
enrich dynactin at the distal end of primary neurons.
While the CAP-Gly domain is not required for sus-
tained transport along the axon, we find that the
distal accumulation facilitates the efficient initiation
of retrograde vesicular transport from the neurite
tip. Neurodegenerative disease mutations in the
CAP-Gly domain prevent the distal enrichment of dy-
nactin thereby inhibiting the initiation of retrograde
transport. Thus, we propose a model in which distal
dynactin is a key mediator in promoting the interac-
tion among themicrotubule, dyneinmotor, and cargo
for the efficient initiation of transport. Mutations
in the CAP-Gly domain disrupt the formation of
the motor-cargo complex, highlighting the specific
defects in axonal transport that may lead to neurode-
generation.
INTRODUCTION
The dynein-dynactin complex is the major minus-end-directed
microtubule (MT) motor for vesicle transport in eukaryotic cells.
While the dynein motor alone is capable of producing force
in vitro, the dynactin complex is a necessary cofactor for motor
function in cells (Schroer, 2004). How dynactin contributes to
dynein function remains unclear. The p150Glued subunit of
dynactin interacts directly with the dynein motor (Karki and Holz-
baur, 1995; Vaughan and Vallee, 1995) and also independently
binds MTs and MT plus-end binding proteins, including EB1
and EB3, via interactions mediated by the N-terminal cytoskel-
eton-associated protein glycine-rich (CAP-Gly) domain (Akhma-
nova and Steinmetz, 2008; Ligon et al., 2003; Waterman-Storer
et al., 1995). These observations led to the hypothesis that the
direct binding of dynactin to the MT enhances the processivity
of dynein during transport (Waterman-Storer et al., 1995). This
hypothesis is supported by in vitro biophysical studies showing
that dynactin increases run lengths and enhances processivityat the single motor level (King and Schroer, 2000; Ross et al.,
2006).
However, recent studies in non-neuronal cells show that the
CAP-Gly domain of p150Glued is not necessary for normal
dynein-mediated transport and localization of organelles
including peroxisomes, lysosomes, and Golgi in either HeLa or
S2 cells (Dixit et al., 2008; Kim et al., 2007). In yeast as well,
the CAP-Gly domain of dynactin is not required for processive
motility by dynein (Kardon et al., 2009) but does promote
dynein-dependent nuclear movement leading to the hypothesis
that the CAP-Gly domain may be necessary only when dynein
needs to generate or sustain high force (Moore et al., 2009).
Overall, these studies suggest that the highly conserved CAP-
Gly domain in dynactin might be fully dispensable for vesicular
transport in the cell.
Strikingly, however, genetic evidence reveals that the CAP-Gly
domain of p150Glued is essential for normal neuronal function
since point mutations within this domain cause two autosomal
dominant human neurodegenerative disorders: Perry syndrome
and distal hereditary motor neuropathy 7B (HMN7B, also known
as distal spinal and bulbar muscular atrophy) (Farrer et al., 2009;
Puls et al., 2003). HMN7B is caused by a glycine to serine substi-
tution at residue 59 (G59S), while Perry syndrome is caused by
one of five point mutations at residues 71, 72, or 74 (G71R,
G71E, G71A, T72P, Q74P) (Figures 1A and 1A0; see Movie S1
available online). The neuronal populations that degenerate in
these two diseases are wholly distinct. HMN7B affects motor
neurons, while Perry syndrome primarily affects dopaminergic
neurons in the substantia nigra (Puls et al., 2005; Wider and
Wszolek, 2008). It remains entirely unclear how these mutations,
only 12–15 amino acids apart, differentially disrupt CAP-Gly
domain function causing two disparate diseases.
Here, we report a specific function for the CAP-Gly domain of
dynactin in neurons. Our data show that the CAP-Gly domain
enhances the distal enrichment of dynactin in the neuron, leading
to efficient flux of cargo from the distal neurite. This function is
separable from the role of dynactin in promoting bidirectional
transport along the axon. Further, we show that the known
disease-associated mutations all affect CAP-Gly function but
differentially affect dynein-mediated transport along the axon,
leading to a potential mechanistic explanation for the differential
cell-type-specific degeneration observed in HMN7B and Perry
syndrome. Together, these studies establish a role for the highly
conserved CAP-Gly domain of dynactin in the efficient initiation
of transport in highly polarized cells. These findings therefore
provide insight into both the regulation of axonal transport inNeuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc. 331
Figure 1. The Highly Conserved CAP-Gly Domain of p150Glued Is Not Required for Axonal Transport of Lysosomes
(A) Schematic of the p150Glued subunit of dynactin. The CAP-Gly domain (green) binds both MTs and MT plus-end binding proteins. The basic domain (yellow)
also independently bindsMTs. The HMN7B (red) and the Perry syndrome (cyan) point mutations are shown below. (A0) Crystal structure of the CAP-Gly domain of
p150Glued modified from (Honnappa et al., 2006) (PDB ID 2HKQ). The GKNDG motif is in green and the disease-associated mutations are colored as in (A). The
HMN7Bmutation is buried at the core of the CAP-Gly domain andmay disrupt protein folding, while the Perry syndromemutations are surface-exposed andmay
predominantly interfere with protein-protein interactions. Also see Movie S1.
(B) Purified vesicles (V) frommouse brain enriched for LAMP1were probed for p150Glued using a polyclonal antibody that recognizes both the full-length and p135
isoforms.
(C) Purified vesicles had an increased ratio of full-length p150Glued to p135 compared to the high speed supernatant (HSS) and high-speed pellet (HSP) fractions.
Mean ± SEM, n = 3 vesicle purifications, ***p < 0.001 compared to HSS, one-way ANOVA Bonferroni post test.
(D) Kymographs of LAMP1-RFPmotility in primary dorsal root ganglion (DRG) neurons imaged at 4 days in vitro (DIV) after transfectionwith two scrambled siRNAs
or two siRNAs to p150Glued. siRNAs were also transfected with wild-type full-length p150Glued (WT) or DCAP-Gly p150Glued (DCAP) resistant to the siRNA.
Kymographs drawn along neurite processes represent movement over time so motile organelles appear as diagonal lines while paused organelles appear as
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mutations in dynactin.
RESULTS
p150Glued, but Not the CAP-Gly Domain, Is Necessary
for Transport along the Axon
Multiple splice forms of p150Glued are expressed in brain,
including a neuronally enriched p135 isoform that lacks the
CAP-Gly domain (Tokito et al., 1996). We asked which p150Glued
isoforms are recruited to cargos actively transported through
the cell. Quantitative analysis of the p150Glued isoforms that
copurified with LAMP1-enriched lysosomal fractions indicated
that the full-length polypeptide is preferentially enriched in this
fraction (Figures 1B and 1C). As dynein drives the motility of
lysosomes along axons (Hendricks et al., 2010), the enrichment
of full-length p150Glued that we observe suggests that the CAP-
Gly domain may serve a specific function in the active transport
of these vesicles.
To directly test this hypothesis, we examined the transport of
lysosomes in primary dorsal root ganglion (DRG) neurons. We
used siRNAs to deplete endogenous p150Glued, and achieved
60% knockdown as compared to neurons treated with scram-
bled control siRNAs (Figures S1A–S1C). Depletion of p150Glued
did not significantly disrupt neurite outgrowth, similar to knock-
down of dynein (He et al., 2005), likely due to the gradual loss
of the target proteins.We used LAMP1-RFP tomonitor lysosome
dynamics in DRG processes, which have a uniform MT polarity
with plus ends oriented distally as assessed by EB3 imaging
(Figure S1D). Quantitative analysis indicated that the motility of
LAMP1-RFP-labeled organelles was not different from that of
organelles labeled with LysoTracker (data not shown).
Depletion of p150Glued resulted in a significant decrease in
the motility of both anterograde and retrograde cargos, with
a corresponding increase in the non-motile fraction compared
to scrambled siRNA-treated neurons (Figures 1D and 1E).
These data show that the p150Glued subunit of the dynein-dynac-
tin complex is necessary for the bidirectional motility of
lysosomes along the axon, consistent with previous studies
demonstrating the reciprocal dependence of dynein and kinesin
motors (Hendricks et al., 2010; Martin et al., 1999; Waterman-
Storer et al., 1997).
Next, we asked if expression of p150Glued lacking the CAP-Gly
domain, DCAP-Gly, could rescue the arrest in motility caused by
the knockdown of endogenous p150Glued, as compared to
rescue with the full-length protein. We used a bicistronic vector
to simultaneously and independently express both siRNA-resis-
tant p150Glued and GFP, a transfection marker. Expression of
either wild-type or DCAP-Gly p150Glued fully rescued the disrup-
tion in motility caused by the knockdown of p150Glued. No signif-
icant differences in the fraction of anterograde, retrograde or
nonmotile events were observed among the scrambled control,vertical lines. Images were acquired at 366ms per frame for 2.2min; scale bars for
first 300 frames, full movies shown in Movie S2.
(E) Lysosomal motility was quantified from the kymographs. Depletion of p150
a corresponding increase in nonmotile events. Expression of either wild-type or
condition. Mean ± SEM, n = 12–15 neurons per condition, ***p < 0.001 compared twild-type, and DCAP-Gly rescue experiments (Figures 1D and
1E; Movie S2).
Analysis of individual tracks from the kymographs showed
no difference in mean instantaneous velocities in either the
anterograde or retrograde direction between wild-type and
DCAP-Gly-expressing neurons, nor did we observe a significant
difference in the number of pauses per track or the number of
motility switches per track (Figures S1E–S1G). Additionally, we
observed no change in the total number, apparent size or distri-
bution of the lysosomes in the axon. Together, our data demon-
strate that while dynactin is required, the CAP-Gly domain of
p150Glued is not necessary for processive motility along the
axon in primary neurons.
TheCAP-GlyDomainEnrichesDynactin atDistal Neurite
Tips
Since the CAP-Gly domain of p150Glued does not contribute to
the processive motility of cargos along the axon, we investigated
other possible functions of the domain. In fungi, dynein and
dynactin are enriched at hyphal tips (Lenz et al., 2006). We there-
fore hypothesized that dynein and dynactin may be similarly
enriched at the ends of mammalian neurons and that this
enrichment is dependent on the CAP-Gly domain.
Neurons were transfected with GFP, a marker for cytoplasmic
volume, and stained for endogenous dynactin and dynein. In the
distal neurite, we observed a striking enrichment of dynactin but
not of dynein, as compared to soluble GFP (Figure 2A). We saw
a similar distal enrichment of dynactin in primary cortical, motor,
and dopaminergic neurons, suggesting that this is a generally
conserved mechanism (Figure S2). Line-scan analysis of the
DRG neurons showed that dynactin accumulates in the distal
neurite significantly more than dynein (Figure 2B). These data
suggest that dynactin is specifically recruited and/or retained
in the distal neurite.
Next, we asked whether the CAP-Gly domain is necessary for
this distal enrichment of dynactin. We overexpressed wild-type
or DCAP-Gly p150Glued in primary DRG neurons using a bicis-
tronic vector that also expresses GFP. Wild-type p150Glued
was clearly enriched at the neurite tip, while neurons expressing
DCAP-Gly p150Glued did not show a similar accumulation (Fig-
ure 2C). We quantified this difference using line-scan analysis
and showed that wild-type p150Glued is significantly enriched
over the distal 10 mm of the neurite tip as compared to DCAP-
Gly p150Glued (Figure 2D). These data demonstrate that the
CAP-Gly domain functions to properly localize dynactin in the
distal neurite.
Kinesin-1, but Not Kinesin-2, Transport Is Necessary
for the Distal Enrichment of Dynactin
Motors from the kinesin superfamily, including kinesin-1 and
kinesin-2, drive the fast axonal transport of vesicular cargos.
The anterograde movement of cytosolic proteins via slow axonalthe x and y axes represent 10 mmand 20 s, respectively. Kymographs show the
Glued significantly disrupted anterograde and retrograde motility and caused
DCAP-Gly p150Glued rescued this disruption; >800 vesicles were counted per
o scrambled siRNAs, one-way ANOVA Bonferroni posttest. Also see Figure S1.
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Figure 2. The CAP-Gly Domain Is Necessary for
the Distal Enrichment of Dynactin in Neurons
(A) Distal ends of DRG neurons expressing GFP were
stained at 2 DIV for endogenous p150Glued or endogenous
dynein heavy chain (DHC) and GFP, as a marker of cyto-
plasmic volume. These images were individually contrast
enhanced to display both axonal and tip staining. The raw
p150 and DHC data were divided by the corresponding
raw GFP signal to create the ratio image (Rp150/GFP or
RDHC/GFP). These images show the distal accumulation
relative to GFP. These ratio images were contrast
enhanced to the same level and a heat mapwas applied to
show the relative intensities of the ratio. Thewarmer colors
represent a higher ratio, while cooler colors represent a
lower ratio.
(B) Line-scan quantification of the distal accumulation.
The normalized ratio of endogenous dynactin or dynein
fluorescence intensity to GFP intensity was determined
along the length of the neurite tip. Expression as a ratio to
soluble GFP controls for changes in cytoplasmic volume.
Dynactin accumulated significantly more than dynein over
the distal 15 mm of the neurite. Mean ± SEM, n R 41
neurite tips from 5–7 neurons per condition, ***p < 0.001,
two-way ANOVA Bonferroni post test.
(C) Images of the distal neurites of DRG neurons ex-
pressing Myc-tagged full-length wild-type or DCAP-Gly
p150Glued and GFP from a bicistronic vector at 2 DIV.
Neurites were stained for Myc and GFP and images individually contrast enhanced to display both axonal and tip staining. The corresponding ratio images
(Rp150/GFP) were made from the raw imaging data and a heat map was applied as described in (A).
(D) Line-scan analysis from the end of the neurite. The normalized ratio of Myc-tagged p150Glued fluorescence intensity to GFP intensity was determined along the
length of the neurite tip. Wild-type p150Glued accumulated significantly more over the distal 10 mmcompared toDCAP-Gly p150Glued. Mean ± SEM, nR 29 neurite
tips from 5–6 neurons per condition, ***p < 0.001, two-way ANOVA Bonferroni post test. Scale bars: 5 mm. Also see Figure S2.
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therefore tested whether the distal enrichment of dynactin is
dependent on kinesin-1 activity by expressing either the domi-
nant-negative kinesin-1 inhibitor, KHC-tail, or the KHC-stalk,
which does not inhibit the motor and was used as a control (Ko-
nishi and Setou, 2009). We found that expression of KHC-tail
disrupts the distal localization of dynactin, while expression of
KHC-stalk had no effect on dynactin localization (Figure 3A).
Line-scan analysis confirmed a significant difference in the distal
accumulation of dynactin after expression of the KHC-tail, as
compared to localization in neurons expressing either the vector
and or the KHC-stalk (Figure 3B).
Kinesin-1 has not been shown to directly interact with dynac-
tin, nor did we observe co-immunoprecipitation of themotor with
p150Glued expressed in COS7 cells (Figure S3). Thus the mecha-
nism leading to kinesin-1-dependent distal localization of dynac-
tin is likely to be indirect. In contrast, previous work has identified
a direct interaction between kinesin-2 and p150Glued (Deacon
et al., 2003). Therefore, we tested whether kinesin-2 may also
contribute to the anterograde transport of dynactin. Expression
of Kif3A-HL, a dominant-negative inhibitor of kinesin-2 lacking
the motor domain (Nishimura et al., 2004), did not disrupt the
distal localization of dynactin observed in DRG neurons (Fig-
ure 3C). Line-scan analysis confirmed the distal enrichment of
dynactin in neurons expressing Kif3A-HL (Figure 3D). Together,
these observations indicate that kinesin-1, but not kinesin-2,
mediates the anterograde delivery of dynactin to the distal
neurite. This may involve either fast axonal transport as both
kinesin-1 and dynactin are enriched in the same vesicular334 Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc.fraction (Hendricks et al., 2010) or slow axonal transport via the
kinesin-1 dependent delivery of cytoplasmic cargos.
The Highly Stable Pool of Distal Dynactin Is Retained
by EBs
To understand the dynamicity of this distal pool of dynactin, we
performed fluorescence recovery after photobleaching (FRAP)
experiments on the distal neurite after expression of either
EGFP-tagged p150Glued or EGFP alone. We found that the
EGFP signal robustly recovered within 20 s while the EGFP-
p150Glued has negligible recovery by 180 s (Figures 4A and 4B).
We calculated the mobile fraction for each construct, and found
that mobility of EGFP-p150Glued was significantly reduced
compared to EGFP (Figure 4C). These data show that the distal
pool of dynactin is highly stable and suggest that dynactin is
actively retained in the distal neurite.
The end-binding proteins (EBs), EB1 and EB3, are clear candi-
dates to retain dynactin in the distal neurite. EBs are enriched
on MT plus ends, forming comet tails, and interact directly with
dynactin via the CAP-Gly domain (Figure 4D). In neurons ex-
pressing mCherry-EB3 there was a significant increase in comet
density in the distal neurite as compared to comet density along
the axon (Figure 4E). Since the distal accumulation of dynactin is
dependent on the CAP-Gly domain, we hypothesized that the
direct interaction of the CAP-Gly domain with the EB proteins
might retain dynactin in the distal neurite.
To test this hypothesis, we depleted endogenous EBs (EB1
and EB3) using siRNA, achieving 80% knockdown of EB1 and
100% knockdown of EB3 as compared to control siRNAs
Figure 3. Kinesin-1, but Not Kinesin-2, Contributes
to the Distal Localization of Dynactin
(A) Distal ends of DRG neurons expressing GFP, GFP-
tagged KHC-stalk or GFP-tagged KHC-tail were stained at
2 DIV for endogenous p150Glued and GFP. These images
were individually contrast enhanced to display both
axonal and tip staining. The raw p150 data was divided by
the corresponding raw GFP signal to create the ratio
image (Rp150/GFP). These images show the distal accu-
mulation relative to GFP. These ratio images were contrast
enhanced to the same level and a heat mapwas applied to
show the relative intensities of the ratio. Thewarmer colors
represent a higher ratio, while cooler colors represent
a lower ratio.
(B) Line-scan quantification of the distal accumulation.
The normalized ratio of endogenous dynactin fluores-
cence intensity to GFP intensity was determined along
the length of the neurite tip. The KHC-tail, a dominant-
negative kinesin-1 inhibitor, significantly disrupted the
localization of dynactin over the distal 9 mm of the neurite
as compared to vector expressing neurons. Mean ± SEM,
nR 46 neurite tips from 7–8 neurons per condition, ***p <
0.001, two-way ANOVA Bonferroni post test.
(C) Distal ends of DRG neurons expressing GFP or GFP-
tagged Kif3A-HL, a dominant-negative kinesin-2 inhibitor,
were stained at 2 DIV for endogenous p150Glued and GFP.
These images were individually contrast enhanced to
display both axonal and tip staining. The ratio images
(Rp150/GFP) were calculated from the raw imaging data and
a heat map was applied as described in (A).
(D) Line-scan quantification of the distal accumulation
as described in (B). Kif3A-HL expression had no effect on
the distal accumulation of dynactin. Mean ± SEM, nR 46
neurite tips from 7 neurons per condition. Also see
Figure S3.
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did not observe any significant defects in neurite outgrowth or
morphology after knockdown of EB1 and EB3. Staining siRNA-
treated neurons for endogenous p150Glued demonstrated that
depletion of the EBs disrupted the distal localization of dynactin
as compared to control neurons (Figure 4H). Line-scan analysis
revealed that knockdown of the EBs resulted in a significant
difference in the localization of dynactin in the distal 7.8 mm of
the axon (Figure 4I). Thus, the increased density of EBs observed
in the distal axon functions to actively retain a highly stable pool
of dynactin in the distal neurite via direct interaction with the
CAP-Gly domain.
The CAP-Gly Domain Enhances Flux from Distal Neurite
Tips
The function of this distal accumulation of dynactin in neurons
is unknown. As full-length p150Glued is enriched on vesicles
(Figure 1B) and the CAP-Gly domain is necessary to concentrate
dynactin in the distal neurite (Figure 2C), we reasoned that the
CAP-Gly domain might promote retrograde transport from the
neurite tip.
We tested this hypothesis by measuring the retrograde flux
of LAMP1 vesicles originating from the 10 mm zone of distally
enriched dynactin. In primary DRG neurons, treated with
siRNA against p150Glued and expressing either full-length or
DCAP-Gly p150Glued, we photobleached the axon in a zone10 mm proximal to the neurite tip to permit visualization of only
those retrograde cargos that originate from the distal neurite
(Figure 5A). We found that the number of vesicles leaving the
distal neurite was significantly reduced (65%) in neurons ex-
pressing DCAP-Gly p150Glued, as compared to either neurons
expressing wild-type p150Glued or untreated control neurons
expressing only LAMP1-RFP (Figure 5B). Thus, the CAP-Gly
domain of p150Glued is necessary for efficient cargo flux from
the neurite tip.
Interestingly, we observed no significant accumulation or
depletion (p = 0.85) of LAMP1 intensity in the distal neurite after
knockdown and rescue with DCAP-Gly p150Glued. These data
show that the decrease in flux we observed is not due to a
decrease in the number of lysosomes and suggest there is likely
a complex regulation of lysosome dynamics in the distal neurite.
Further, we photobleached LAMP1 in the midaxon (>100 mm
from the neurite end) and observed no change in the retrograde
flux of lysosomes after p150Glued knockdown and rescue with
either wild-type or DCAP-Gly p150Glued (Figure S4). These data
are consistent with the axonal transport data presented in Fig-
ure 1 and show that the CAP-Gly domain of p150Glued is not
necessary for sustained vesicular transport along the axon.
Thus, we show that the CAP-Gly domain is important for the
efficient initiation of transport specifically from the distal neurite
but is dispensable for transport along the axon. We propose
a model in which the distally enriched dynactin acts a keyNeuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc. 335
Figure 4. EBs Are Necessary to Maintain the Highly Stable Pool of Distal Dynactin
(A) FRAP time series of the distal tip of DRG neurons at 2 DIV expressing either EGFP or EGFP-p150Glued. The yellow box demarcates the photobleached region.
Each image in the time series was contrast enhanced equally. Also see Movie S3.
(B) Mean FRAP recovery curve ± SEM, n = 10–11 neurites per condition. Photobleaching occurred at time = 0.
(C) The mobile fraction for each individual FRAP trace was determined by fitting the trace to a single exponential equation. The mean mobile fraction was
determined for EGFP and EGFP-p150Glued expressing neurons ± SEM, n = 10–11 traces per condition, ****p < 0.0001, Student’s t test.
(D) Quantification of EB1 binding as percent bound relative to wild-type. WT and DCAP p150Glued fragments were synthesized in vitro and incubated with either
EB1-conjugated or empty beads. Mean ± SEM, n = 4 independent experiments, *p < 0.05, Student’s t test. Also see Figure S5.
(E) The number of EB3 comets was counted from time-lapse movies of DRG neurons at 2 DIV expressing mCherry-EB3. Distal neurite is defined as the distal
10 mmof the neurite while themidaxon is defined as a 10 mmregion of the axon >50 mmproximal to the neurite end.Mean ± SEM, n = 21movies per condition, **p <
0.01, Student’s t test.
(F) Lysate from DRG neurons at 4 DIV after treatment with either control siRNAs or siRNA directed against EB1 and EB3 was probed for EB1, EB3, and b-catenin.
(G) Quantification by Western blot of EB1 and EB3 levels after siRNA knockdown showed approximately 80% and 100% knockdown of EB1 and EB3,
respectively. Western blot values were normalized to b-catenin as a loading control.
(H) Distal ends of DRG neurons at 4 DIV stained for endogenous p150Glued and GFP after transfection with GFP and either control siRNAs or siRNAs against EB1
and EB3. These images were individually contrast enhanced to display both axonal and tip staining. The ratio images (Rp150/GFP) were calculated from the raw
imaging data by dividing the raw p150 data by the corresponding rawGFP signal. These images show the distal accumulation relative to GFP. These ratio images
were contrast enhanced to the same level and a heatmapwas applied to show the relative intensities of the ratio. Thewarmer colors represent a higher ratio, while
cooler colors represent a lower ratio.
(I) Line-scan quantification of the distal accumulation. The normalized ratio of endogenous dynactin fluorescence intensity to GFP intensity was determined along
the length of the neurite tip. Expression as a ratio to soluble GFP controls for changes in cytoplasmic volume. Knockdown of EB1 and EB3 significantly reduced
the distal accumulation of dynactin over 7.8 mm from the distal axon. Mean ± SEM, nR 49 neurite tips from 9–12 neurons per condition, ***p < 0.001, two-way
ANOVA Bonferroni post test. Scale bars: 5 mm.
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Figure 5. The CAP-Gly Domain Enhances the
Retrograde Flux of Cargo from the Distal Axon
DRG neurons were imaged at 4 DIV after transfection with
siRNA to deplete endogenous p150Glued and rescued with
either wild-type or DCAP-Gly p150Glued. The retrograde
flux of LAMP1-RFP cargo from the end of the neurite was
measured following photobleaching of a zone 10 mm
proximal to the neurite end. Entry of cargos from the distal
tip into this bleach zone was assessed with time-lapse
imaging. Images were acquired at 2 frames per second for
5 s prephotobleaching and 120 s postphotobleaching.
(A) Kymographs of the photobleached zone were made
prior to and subsequent to photobleaching to assess the
retrograde flux of cargo from the distal neurite. Scale bars
for the x and y axes represent 5 mm and 20 s, respectively.
On the right, for illustrative purposes, the retrograde
moving cargos were traced over in blue, the time of pho-
tobleaching is marked in red and the point where flux
measurements were made is in orange.
(B) Retrograde vesicle flux was determined by counting
the number of retrograde vesicles that moved at least
3.5 mm into the photobleached zone from the distal neu-
rite. Rescue with DCAP-Gly p150Glued significantly
decreased the flux from the distal neurite as compared to
either rescue with wild-type p150Glued or control neurons
not treated with siRNA. Mean ± SEM, n > 11 neurites from
6–14 neurons per condition, **p < 0.01, compared to wild-
type, one-way ANOVA Bonferroni post test.
(C) Model for the function of the CAP-Gly domain of
p150Glued in neurons. The CAP-Gly domain is necessary to
distally enrich p150Glued in neurite tips and facilitate the
flux of cargo from the neurite end. Also see Figure S4.
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and cargo to facilitate the formation of a motile motor-cargo
complex and promote the efficient flux of cargos out of the distal
neurite (Figure 5C).
Perry Syndrome Mutants Disrupt CAP-Gly Interactions,
While theHMN7BMutant Is Aggregation Prone andDoes
Not Associate with Dynein
We used the Perry syndrome and HMN7B disease mutations to
test ourmodel for the function of the CAP-Gly domain in neurons.
Although the point mutations that cause these two diseases are
close in primary sequence, they map to distinct regions of the
three-dimensional structure of the CAP-Gly domain (Figures 1A
and 1A0; Movie S1). The HMN7B mutation alters a highly
conserved glycine residue in the center of the globular domain.
This glycine residue is important in maintaining the fold of the
domain (Li et al., 2002), so mutation of this residue to a larger
serine residue is predicted to decrease protein stability. In
contrast, the Perry syndrome mutations are surface exposed.
These residues are within or near the conserved GKNDG motif
important in forming the highly conserved groove necessary
for binding tubulin and EBs (Hayashi et al., 2005; Honnappa
et al., 2006), so these mutations will likely disrupt these
protein-protein interactions. Thus we hypothesized that the
HMN7B and Perry syndrome mutations differentially disrupt
CAP-Gly function due to the their location within distinct regions
of the CAP-Gly domain.
Both the HMN7B (G59S) and the Perry syndrome (G71R,
Q74P) mutations decrease the affinity of p150Glued for MTsin vitro, similar to the binding affinity observed with DCAP-Gly
p150Glued (Figures S5A–S5C). In assays examining overexpres-
sion of the disease-associated mutations in COS7 cells, we
also observed a loss of MT binding similar to that induced by
expression of DCAP-Gly p150Glued (Figures S6A and S6B).
In vitro binding experiments also showed that the HMN7B
(G59S) and Perry syndrome (G71R, Q74P) mutations signifi-
cantly disrupt the interaction of p150Glued with EB1 (Figures
S5D and S5E). Together, these results indicate that both the
HMN7B and Perry syndrome mutations cause a loss of CAP-
Gly function.
Interestingly however, we noted a difference between the
cellular phenotype of the HMN7B and Perry syndrome muta-
tions. The Perry syndrome mutations (G71R, Q74P) predomi-
nately phenocopy the diffuse staining pattern observed upon
expression of DCAP-Gly p150Glued. In contrast, the HMN7B
(G59S) mutation had a greater propensity to aggregate (Figures
S6A and S6B). In vitro studies further support this observation,
as the HMN7B mutation induced the formation of p150Glued
aggregates significantly more than either wild-type or the Perry
syndrome mutants (Figures S6C and S6D). These data, along
with previous observations (Levy et al., 2006), show that the
HMN7B mutation decreases p150Glued stability while the Perry
syndrome mutations do not.
We next asked if the increased aggregation of the HMN7B
protein disrupts the integrity of the dynein-dynactin complex.
We coexpressed Myc-tagged wild-type or mutant forms of
p150Glued along with HA-tagged wild-type p150Glued in COS-7
cells and performed coimmunoprecipitation assays (Figure 6).Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc. 337
Figure 6. Decreased Association of HMN7B
Mutant Dynactin with Dynein
(A) Myc-tagged wild-type (WT), HMN7B (G59S), Perry
syndrome (G71R and Q74P), and DCAP-Gly p150Glued
were coexpressed with wild-type HA-tagged p150Glued in
COS-7 cells; LSS, low-speed supernatant.
(B) Immunoprecipitation (IP) was performed using an anti-
Myc antibody. Immunoprecipitates were probed for the
Myc- and HA-tagged p150Glued constructs to assess
dimerization. Immunoblot (IB) for dynamitin/p50, a subunit
of the dynactin complex, and the dynein intermediate
chain, DIC, was performed to assess incorporation into
the dynein-dynactin complex. GAPDH was probed for as
a negative control. Quantification of p150Glued dimeriza-
tion (C), incorporation into dynactin (D) and association
with dynein (E), relative to wild-type. Insets above the
graphs illustrate the association tested. Mean ± SEM, n =
3–4 independent experiments, **p < 0.01 compared to
wild-type, one-way ANOVA Bonferroni post test. Also see
Figures S5 and S6.
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the Perry syndrome (G71R and Q74P) and HMN7B (G59S)
mutants (Figure 6C). These mutants also coimmunoprecipitated
endogenous p50/dynamitin, another subunit of dynactin (Fig-
ure 6D). Together, these data show that both the Perry syndrome
and HMN7B mutants dimerize with wild-type p150Glued and are
incorporated into the dynactin complex.
However, we observed a striking difference in the co-immuno-
precipitation of the dynein intermediate chain (DIC) between
the HMN7B (G59S) and Perry syndrome (G71R, Q74P) mutants.
The Perry syndrome mutants associated with DIC as strongly as
wild-type p150Glued, while the HMN7B mutant exhibited a signif-
icantly decreased association (Figure 6E). These data suggest
that although the HMN7B mutation incorporates into dynactin,
it does not efficiently bind to dynein. The decrease in association
with dynein is likely a consequence of the altered confirmation of
the HMN7B protein rather than direct perturbation the binding
motif, since glycine-59 is distant from the previously identified
DIC interaction region of p150Glued (Karki and Holzbaur, 1995;
Vaughan and Vallee, 1995).
The HMN7B Mutation Disrupts Transport within the
Axon
As a consequence of the decreased association with dynein, we
hypothesized that the HMN7B mutation would disrupt axonal
transport while the Perry syndrome mutations would not. To
test this hypothesis, we examined the transport of LAMP1-RFP
in mouse primary DRG neurons expressing mutant p150Glued.
The HMN7B (G59S) mutation caused a significant decrease in
the number of retrograde and anterograde moving vesicles with
a corresponding increase in the non-motile fraction (Figures 7A
and 7B;Movie S5).We compared the extent of inhibition induced338 Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc.by the G59S mutation to the inhibition of trans-
port caused by CC1. CC1 is a dominant-nega-
tive inhibitor of the dynein-dynactin interaction
that effectively dissociates dynein and dynactin
(Quintyne et al., 1999). Expression of CC1,similar to the HMN7B mutation and p150Glued depletion (Fig-
ure 1), caused a significant decrease in the number moving
cargos and a corresponding increase in the nonmotile fraction
(Figures 7A and 7B; Movie S4). Immunostaining of neurons ex-
pressing the HMN7B mutant protein did not indicate the forma-
tion of frank G59S aggregates in the neuron, suggesting that
the disruption in transport we observed was not due a steric inhi-
bition of transport. Instead, these data suggest that HMN7B
mutation disrupts the flux of cargos by disrupting the interaction
between dynein with dynactin, similar to the effects of CC1.
Importantly, these data suggest that the primary pathogenic
mechanism involved in HMN7B is a disruption of axonal
transport.
Analysis of individual tracks from the kymographs revealed
that the HMN7B (G59S) mutation decreased the mean velocities
of both anterograde and retrograde transport (Figures 7C and
S7). Additionally the number of pauses per track and the
number of motility switches per track were increased (Figures
7D and 7E). Together these data suggest that disruption of the
dynein-dynactin interaction affects multiple parameters of
dynein-mediated retrograde motility. Dominant-negative disrup-
tion decreases mean velocity and also increases the number of
pauses and directional switches.
In contrast, overexpression of either Perry syndrome (G71R,
Q74P) mutations or DCAP-Gly p150Glued did not alter transport
within the axon (Figure 7; Movies S4 and S5). There were no
significant differences in any of the parameters of transport we
measured among wild-type, DCAP-Gly or the Perry syndrome
mutations (Figures 7 and S7). At 2 DIV, we observed no signifi-
cant cell death induced by expression of the mutations, nor did
we observe any change in the total number or apparent size of
lysosomes after expression of either the HMN7B (G59S) or Perry
Figure 7. The HMN7B Mutation, but Not the Perry Syndrome Mutations, Disrupts Axonal Transport
(A) Kymographs from live-cell time-lapse imaging of LAMP1-RFP in DRG neurons at 2 DIV expressing wild-type (WT), DCAP-Gly, CC1, HMN7B (G59S), or Perry
syndrome (G71R and Q74P) p150Glued. Images were acquired at 366 ms per frame for 2.2 min; scale bars for the x and y axes represent 10 mm and 20 s,
respectively. Kymographs show the first 180 frames; full movies shown in Movies S4 and S5.
(B) Quantification of vesiclemotility from the kymographs showed that only theHMN7B (G59S)mutation andCC1 disruptmotility; >575 vesicles were counted per
condition. Mean ± SEM, n = 5–8 neurons per condition, *p < 0.05, **p < 0.01 compared to wild-type, one-way ANOVA Bonferroni posttest.
(C–E) Individual tracks from the kymographswere analyzed. (C)Mean anterograde and retrograde instantaneous velocities ± SD, n > 800 instantaneous velocities
per condition per direction. Also see Figure S7. Quantification of the number of pauses per track (D) and motility switches per track (E). Mean ± SEM,
n > 23 vesicles per condition, **p < 0.01 compared to wild-type, one-way ANOVA Bonferroni posttest.
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Dynactin Is Required for Transport Initiationsyndrome (G71R, Q74P) mutants. These data show that loss of
CAP-Gly domain function does not have a dominant effect on
transport along the axon and that the primary defect in Perry
syndrome, unlike HMN7B, is not a disruption of transport within
the axon.
The Perry Syndrome Mutation Decreases Flux from
Neurite Tips
Since the CAP-Gly domain is necessary to enrich dynactin in
distal neurites through an interaction with EBs (Figures 2 and 4)
and both the Perry syndrome and HMN7B mutations inhibit
the binding of p150Glued to EBs (Figure S5), we asked whether
the disease-associated mutations alter the accumulation of
p150Glued in distal neurites. Neither the Perry syndrome (G71R,Q74P) nor HMN7B (G59S) mutations showed any distal enrich-
ment at the neurite tip compared to expression of wild-type
p150Glued (Figures 8A and 8B). Significant differences in the
accumulation of wild-type p150Glued compared to the Perry
syndrome and HMN7B mutations occur over the first 14 mm
from the neurite tip; however, expression of the mutants did
not alter neurite morphology. These data further support the
conclusion that both the Perry syndrome and HMN7Bmutations
disrupt CAP-Gly function. For the HMN7B mutation, however, it
is unclear if the decreased distal accumulation is caused by
a decreased affinity for EBs, or is due to bidirectional inhibition
of transport caused by expression of this protein, as anterograde
transport is also required to establish the distal dynactin pool
(Figure 3).Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc. 339
Figure 8. Perry Syndrome Mutant Disrupts Flux
from the Distal Neurite
(A) DRG neurons were stained at 2 DIV for Myc-tagged
wild-type (WT), HMN7B (G59S), or Perry syndrome (G71R
and Q74P) p150Glued and GFP, a marker of cytoplasmic
volume, expressed from a bicistronic vector. These distal
neurite images were individually contrast enhanced to
display both axonal and tip staining. The raw Myc-p150
data was divided by the corresponding raw GFP signal to
create the ratio image (Rp150/GFP), which shows the distal
accumulation relative to GFP. These ratio images were
contrast enhanced to the same level and a heat map was
applied to show the relative intensities of the ratio. The
warmer colors represent a higher ratio, while cooler colors
represent a lower ratio. Scale bar: 5 mm.
(B) Line-scan analysis from the neurite tip. The normalized
ratio of myc-p150Glued to GFP fluorescence intensity was
determined along the length of the neurite. Wild-type
p150Glued accumulated significantly more over the first
14 mm as compared to mutant p150Glued. The WT-p150
data was replotted from Figure 2D. Mean ± SEM, nR 29
neurite tips from 4–6 neurons per condition, ***p < 0.001
compared to wild-type, two-way ANOVA Bonferroni
posttest.
(C) DRG neurons expressing wild-type or G71R p150Glued
were imaged at 2 DIV. The retrograde flux of LAMP1-RFP
from the neurite tip was measured following photo-
bleaching of a zone 10 mm proximal to the end of the
neurite. Entry of cargos from the distal tip into this bleach
zone was assessed with time-lapse imaging. Images were
acquired at 2 frames per second for 5 s prephotobleaching
and 120 s postphotobleaching. Kymographs of the pho-
tobleached zone were made prior to and subsequent to
photobleaching to assess the retrograde flux of cargo
from the distal neurite.
(D) Retrograde vesicle flux was determined by counting
the number of retrograde vesicles that moved at least
3.5 mm into the photobleached zone. The Perry syndrome
(G71R) mutation dominantly decreased retrograde flux
from the distal neurite. Mean ± SEM, n = 14–16 neurites
from 8 neurons per condition, **p < 0.01 Student’s t test.
(E) Model of how the Perry syndrome and HMN7B mutations differentially disrupt dynactin function. The wild-type model is redrawn from Figure 5C. The Perry
syndrome mutations decrease distal dynactin accumulation and reduce the flux of cargo from the neurite tip. The HMN7B mutation destabilizes dynactin, which
decreases the association between dynein and dynactin and disrupts transport throughout the axon.
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initiation of transport from the distal neurite (Figure 5). Therefore,
the decreased distal accumulation caused by expression of
the Perry syndrome mutations suggests that this will in turn
cause decreased cargo efflux from the neurite tip. We tested
this by photobleaching a region 10 mm proximal to the end of
the neurite and observed the retrograde flux into the photo-
bleached zone (Figure 8C). Expression of the G71R Perry
syndrome mutation had a dominant-negative effect and signifi-
cantly disrupted retrograde flux, as compared to overexpression
of wild-type p150Glued (Figure 8D). These data suggest that the
primary pathogenic mechanism in Perry syndrome is a decrease
in the efficiency of retrograde transport from the distal axon
(Figure 8E).
DISCUSSION
We have demonstrated a required function of the conserved
CAP-Gly domain of dynactin in facilitating the efficient initiation340 Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc.of transport from the distal axon. We show that the CAP-Gly
domain of p150Glued is necessary to enrich dynactin in distal
neurites and that this enrichment promotes the flux of cargo
out of the neurite tip. Kinesin-1 delivers dynactin to the distal
neurite, while EBs retain dynactin distally and may also promote
the initiation of transport by recruiting dynactin onto the MT plus
end. Once transport is initiated, the CAP-Gly domain is not
necessary for transport of cargo along the axon.
The identification of the CAP-Gly motif of dynactin as an
independent MT-binding domain initially suggested that it might
act to enhance the processivity of the dynein motor (Hendricks
et al., 2010; King and Schroer, 2000; Ross et al., 2006;
Waterman-Storer et al., 1995). However, studies in S2 and
HeLa cells as well as yeast show that the domain is dispensable
for most interphase dynein-mediated activity in small and/or
nonpolarized cells (Dixit et al., 2008; Kardon et al., 2009; Kim
et al., 2007; Moore et al., 2009).
Here, we show that while full-length p150Glued is enriched on
vesicles, the CAP-Gly domain does not contribute to the motility
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Dynactin Is Required for Transport Initiationof these vesicles along the axon. Rather, we propose a model in
which the CAP-Gly domain serves a specialized function at the
neurite tip (Figure 5C). The domain is necessary to enrich dynac-
tin in the distal neurite and promote the efficient initiation of retro-
grade transport. Previous studies have suggested that both
p150Glued and the related CAP-Gly protein, CLIP-170, may be
important in the capture of dynamic MTs for the initiation of
minus-end-directed transport (Lomakin et al., 2009; Vaughan
et al., 2002).
We find that the distal accumulation of dynactin is dependent
on kinesin-1-mediated transport. Dynactin may be delivered to
the distal neurite via fast axonal transport, on anterograde-
moving vesicles, or via slow axonal transport, which delivers
cytoplasmic cargo and is also kinesin-1 dependent (Scott
et al., 2011). Neither mechanism is likely to involve a direct inter-
action with dynactin. While dynein does interact with kinesin-1
(Ligon et al., 2004), in these experiments we did not observe
a distal accumulation of dynein by immunocytochemistry.
The pool of distally enriched dynactin is highly stable, suggest-
ing a mechanism of active retention at the neurite tip. We show
that the end-binding proteins, EB1 and EB3, are necessary to
maintain this distal pool. Although the length of a single EB
comet is 0.5–2 mm, enrichment of +TIP proteins in a spatially
restricted domainmay provide a platform for spatial organization
in the cell (Akhmanova and Steinmetz, 2008). Thus, the
increased EB3 comet density we observe in the distal neurite
leads to the preferential enrichment and retention of dynactin
in the distal neurite. In an interesting parallel, dynactin is
observed to accumulate in the distal hyphal tip of filamentous
fungi. Further, this localization is dependent on the MT plus-
end binding protein, Peb1, which binds to the CAP-Gly domain
(Lenz et al., 2006; Schuster et al., 2011), paralleling our observa-
tions in neurons.
We propose amodel in which the distal enrichment of dynactin
enhances the coupling of dynein to the cargo and the MT to
increase the efficient initiation of transport (Figure 5C). The
CAP-Gly domain is necessary to enrich and retain dynactin
distally where dynactin can directly interact with cargos such
as late endosomes and lysosomes as well as dynein and MTs
(Johansson et al., 2007; Karki and Holzbaur, 1995; Waterman-
Storer et al., 1995). Thus, dynactin may be the key mediator in
the formation of a motile motor-cargo complex. The distal
enrichment of dynactin may promote the initial interaction of
dynactin with the MT and cargo followed by the recruitment of
the dynein motor. Dynein recruitment may be the limiting step
in the initiation of retrograde transport of the motor-cargo
complex.
Axons are longer than any single MT, so cargos must switch
MT tracks to efficiently transit along the axon. It is possible
that dynactin also promotes this switching for vesicles in transit,
by promoting the efficient formation of a cargo-motor-MT
complex following interruption of motility along the axon caused
by a gap in the MT track. However, our observations that a
DCAP-Gly construct could fully rescue transport along the
mid-axon suggests that this activity is not strongly required to
maintain normal transport.
The importance of the CAP-Gly domain in dynactin to neuronal
function is highlighted by the multiple disease-causing pointmutations identified in this motif to date. Here, we show that
the mechanisms driving the pathogenesis of HMN7B and Perry
syndrome are distinct. The HMN7B mutation affects a residue
important for maintaining the structure of the CAP-Gly domain
so the mutation promotes misfolding and aggregation (Levy
et al., 2006). This aggregation decreases the stability of the
dynactin complex, preventing effective association between
dynein and dynactin and ultimately disrupts axonal transport
(Figure 8E). The Perry syndrome mutations, in contrast, are
surface-exposed and more specifically disrupt protein-protein
interactions. The Perry syndrome mutations phenocopy DCAP-
Gly p150Glued in all our assays, which suggests that the primary
pathogenic mechanism in Perry syndrome is a loss of CAP-Gly
function. Consistent with this, we observe a decrease in the
efficiency of cargo flux from the distal neurite in Perry syndrome
(Figure 8).
Our data on the HMN7B and Perry syndrome mutations are
consistent with the pathology observed in patients and in
available mouse models (Chevalier-Larsen et al., 2008; Lai
et al., 2007; Laird et al., 2008). HMN7B patients have significant
deposits of dynactin in motor neurons (Puls et al., 2005), while
minimal aggregates of dynactin are observed Perry syndrome
patients (Farrer et al., 2009). These data support a model in
which the HMN7B mutation decreases p150Glued stability due
to the critical location of glycine-59 for maintaining domain
structure. In contrast, the Perry syndrome mutants cause a
loss of function with no change in protein stability. Initial studies
examining the effects of the Perry syndrome mutations on MT
binding have yielded conflicting results (Ahmed et al., 2010;
Farrer et al., 2009). However, our data clearly show that the Perry
syndrome mutations cause a loss of CAP-Gly function, resulting
in a decrease in transport initiation from the distal neurite.
How do these distinct mechanisms result in the disease
phenotypes associated with HMN7B and Perry syndrome?
Defects in axonal transport have been observed in models of
motor neuron disease and other neurodegenerative diseases
(Perlson et al., 2009; Perlson et al., 2010). We speculate that
multiple factors play a role in the selectivity of cell death. The
HMN7B mutant protein is preferentially degraded in vivo (Lai
et al., 2007), suggesting that most cells recognize the decreased
stability of the protein and can effectively target the polypeptide
for degradation. However, motor neurons may not effectively
induce a stress response to protein misfolding (Batulan et al.,
2003), leaving them vulnerable to the dominant-negative effect
of the G59S mutation. In contrast, the distinct morphology of
dopaminergic neuronsmaymake these cells uniquely vulnerable
to defects in the initiation of retrograde transport. The immense
axonal arborizations of dopaminergic neurons (Matsuda et al.,
2009) suggest that the loss-of-function effects of the Perry muta-
tions may critically affect this cell type.
Thus, our data inform normal dynein-dynactin function as
well as the selective vulnerabilities of discrete populations of
neurons to specific perturbations in the cellular function of
these proteins. The two distinct mechanisms we propose for
the pathogenesis of HMN7B and Perry syndrome highlight the
specialized function of a single domain of dynactin and provide
a model for the function of the CAP-Gly domain of p150Glued in
neurons.Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc. 341
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DRG Culture and Transfections
Dorsal root ganglia (DRGs) were dissected from adult mice less than 1 year old
and treated with 20 U/ml papain, followed by 2 mg/ml collagenase II and
2.4 mg/ml dispase II. Neurons were then dissociated in HBSS, supplemented
with 5mMHEPES and 10mMD-glucose (pH 7.35), and purified through a 20%
Percoll gradient for 8 min at 1,000 3 g. DRG neurons were transfected with
either DNA, siRNAs or both using the basic neuron SCN nucleofector kit
(Lonza) and then plated onto 0.01% poly-L-lysine and 20 mg/ml laminin coated
coverslips or glass-bottom dishes (FluoroDish, World Precision Instruments)
and grown for 2–4 days in F-12 medium supplemented with 10% heat-inacti-
vated FBS and 100 U/ml penicillin-streptomycin. Live-cell imaging was done in
Hibernate-A (Brain Bits, Springfield IL) supplemented with 2% B27 supple-
ment (Invitrogen) and 2 mM GlutaMax (GIBCO). All experiments involving
animals were approved by the IACUC at the University of Pennsylvania.Microscopy
Images of LAMP1-RFP motility (Figures 1 and 7) were acquired 366 ms per
frame for 360 frames. Images were acquired in epifluorescence on an inverted
Leica DMI-6000/CTR-7000HS microscope with an Apochromat 633 1.4 NA
oil-immersion objective in a temperature-controlled chamber (37C) with an
ORCA R2 (Hamamatsu) camera using LAS-AF (Leica) software. Fixed cells
were imaged in epifluorescence, as described above. Neurons were imaged
with a 1.63 magnifier.
Photobleaching of LAMP1-RFP (Figures 5A, 8C, and S4) and FRAP of EGFP
or EGFP-p150Glued (Figure 4A) was performed in a temperature-controlled
chamber (37C) using the 561 nm or 488 nm laser, respectively, at 100%
power for 25 cycles on the Ultraview Vox (PerkinElmer) spinning disk confocal
system with an Ultraview Photokinesis (PerkinElmer) unit on an inverted Nikon
Ti microscope with apochromat 1003 1.49 NA oil-immersion objective and
a C9100-50 EM-CCD (Hamamatsu) camera controlled by Volocity (Perki-
nElmer) software. mCherry-EB3 was imaged using the 561 nm laser at 2 s
per frame for 5 min. For LAMP1-RFP photobleaching experiments, images
were acquired using the 561 nm laser at 2 frames per second for 5 s prior to
and for 120 s subsequent to photobleaching. For FRAP, images were acquired
using the 488 nm laser at 1 frame per second for 5 s prior to and for 180 s
subsequent to photobleaching. FRAP curves were fit to the single exponential
equation, f(t) = A(1  ett), where A is mobile fraction.Image Analysis
Kymographs from time-lapse imaging data were made using the Multiple
Kymograph plugin (submitted by J. Rietdorf and A. Seitz, European Molecular
Biology Laboratory, Heidelberg, Germany) in ImageJ (NIH). All tracks from
each LAMP1-RFP kymograph were classified as either anterograde, retro-
grade, or nonmotile. Cargos that moved net distances greater than 10 mm in
a single direction were classified as either anterograde or retrograde. Cargos
that moved less than 10 mm were classified as nonmotile.
The tracks of individual lysosomes, moving greater than 10 mm, were deter-
mined in ImageJ by marking points where the slope changes and interpolating
the intermediate points of the track using a linear function. The instantaneous
velocities, pauses per track and motility switches per track were calculated
from this data. A pause was defined as an instantaneous velocity less than
100 nm per second. A motility switch is defined as a change in the direction
of motility (anterograde to retrograde or vice versa) or switch from directional
motility (anterograde or retrograde) to a pause and vice versa.
Line-scan fluorescence intensity quantification was performed on raw
imaging data using Metamorph. A line starting at the distal end of the neurite
was drawn along the process toward the cell body and the florescence inten-
sity was measured along the line. The fluorescence intensity of both channels
was normalized to the minimum value of each line. The normalized intensities
were divided by the corresponding normalized GFP intensity and plotted as
a function of distance from the neurite tip.
The retrograde flux of LAMP1-RFP was measured from kymographs of the
photobleached region of the axon, which were made prior to and subsequent
to the photobleaching in Volocity (PerkinElmer). Vesicles originating from the342 Neuron 74, 331–343, April 26, 2012 ª2012 Elsevier Inc.distal end and moved at least 50 pixels (3.5 mm) into the photobleached
zone were considered retrograde moving cargos.
Immunoprecipitation
To test for coimmunoprecipitation of dynactin, COS-7 cells were cotrans-
fected with Myc-tagged p150Glued isoforms and HA-tagged wild-type
p150Glued using FuGENE 6 (Roche) for 24 hr. Cells were lysed in 100 mM
PIPES, 1 mM EGTA, 2 mM MgCl2, 25 mM NaCl, 0.5 mM DTT, 1% Triton
X-100, and protease inhibitors (1 mM PMSF, 1 mM Leupeptin, 0.001 mg/ml
Pepstatin-A and 0.01 mg/ml TAME). To test for coimmunoprecipitation of
KHC with p150Glued, COS-7 cells were transfected with Myc-tagged p150Glued
isoforms and lysed in the above buffer except with 0.25% Triton X-100. Immu-
noprecipitations were performed using Protein G coupled Dynabeads (Invitro-
gen). Beads were washed in the above buffer without the detergent and
eluates were analyzed by SDS-PAGE and western blot.
Statistical Methods
Statistics were performed in Prism (GraphPad) software. When comparing
multiple data sets, statistical significance was determined by using a one-
way or two-way ANOVA with a Bonferroni post test. A Student’s t test was
used to determine statistical significance when comparing two data sets.
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